Author(s):
Aditya Kiran Gatta, Nancy V Philip, Raghu Chandrashekhar H, N Udupa, Meka Sreenivasa Reddy, Srinivas Mutalik, Venkata Rao Josyula
Email(s):
g.adi750@gmail.com , nancyphilip26@gmail.com , raghushekhar@gmail.com , n.udupa@manipal.edu , ms.reddy@manipal.edu , ss.mutalik@manipal.edu
DOI:
10.5958/0974-360X.2021.00011.1
Address:
Aditya Kiran Gatta, Nancy V Philip, Raghu Chandrashekhar H, N Udupa, Meka Sreenivasa Reddy, Srinivas Mutalik, Venkata Rao Josyula
Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Karnataka 576104.
*Corresponding Author
Published In:
Volume - 14,
Issue - 1,
Year - 2021
Cite this article:
Aditya Kiran Gatta, Nancy V Philip, Raghu Chandrashekhar H, N Udupa, Meka Sreenivasa Reddy, Srinivas Mutalik, Venkata Rao Josyula. Strategic design of potential siRNA molecules for in vitro Evaluation in ABCG2 resistant Breast cancer and in vivo toxicity Determination. Research J. Pharm. and Tech. 2021; 14(1):55-61. doi: 10.5958/0974-360X.2021.00011.1